Sangamo Therapeutics Inc (SGMO)
0.519
-0.02
(-4.17%)
USD |
NASDAQ |
Apr 17, 16:00
0.51
-0.01
(-1.73%)
After-Hours: 20:00
Sangamo Therapeutics Total Return Level: 0.5416 for April 16, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 16, 2024 | 0.5416 |
April 15, 2024 | 0.5551 |
April 12, 2024 | 0.5434 |
April 11, 2024 | 0.5452 |
April 10, 2024 | 0.524 |
April 09, 2024 | 0.5624 |
April 08, 2024 | 0.5654 |
April 05, 2024 | 0.5612 |
April 04, 2024 | 0.5747 |
April 03, 2024 | 0.61 |
April 02, 2024 | 0.5814 |
April 01, 2024 | 0.6076 |
March 28, 2024 | 0.6702 |
March 27, 2024 | 0.6247 |
March 26, 2024 | 0.6034 |
March 25, 2024 | 0.6417 |
March 22, 2024 | 0.703 |
March 21, 2024 | 0.9703 |
March 20, 2024 | 0.8161 |
March 19, 2024 | 0.77 |
March 18, 2024 | 0.851 |
March 15, 2024 | 0.78 |
March 14, 2024 | 0.78 |
March 13, 2024 | 0.7851 |
March 12, 2024 | 0.8611 |
Date | Value |
---|---|
March 11, 2024 | 0.8824 |
March 08, 2024 | 0.9061 |
March 07, 2024 | 0.9193 |
March 06, 2024 | 1.01 |
March 05, 2024 | 1.03 |
March 04, 2024 | 1.02 |
March 01, 2024 | 1.11 |
February 29, 2024 | 1.16 |
February 28, 2024 | 1.07 |
February 27, 2024 | 1.13 |
February 26, 2024 | 1.12 |
February 23, 2024 | 1.13 |
February 22, 2024 | 1.10 |
February 21, 2024 | 1.235 |
February 20, 2024 | 1.18 |
February 16, 2024 | 1.38 |
February 15, 2024 | 1.05 |
February 14, 2024 | 0.7538 |
February 13, 2024 | 0.6701 |
February 12, 2024 | 0.805 |
February 09, 2024 | 0.5744 |
February 08, 2024 | 0.55 |
February 07, 2024 | 0.4847 |
February 06, 2024 | 0.5207 |
February 05, 2024 | 0.56 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.2971
Minimum
Nov 10 2023
18.18
Maximum
Dec 23 2020
6.880
Average
7.72
Median
Feb 06 2020
Total Return Level Benchmarks
AIM ImmunoTech Inc | 0.4951 |
Perspective Therapeutics Inc | 1.46 |
Protalix BioTherapeutics Inc | 1.14 |
Electromed Inc | 14.40 |
Armata Pharmaceuticals Inc | 3.20 |